Viropharma, Inc. (VPHM) Tops Q4 EPS by 19c, Sales Top Expectations

Viropharma, Inc. (NASDAQ: VPHM) reported Q4 EPS of $0.61, $0.19 better than the analyst estimate of $0.42. Revenue for the quarter came in at $145.6 million versus the consensus estimate of $144.65 million.

Viropharma, Inc. sees FY2012 revenue of $600-$660 million.

For earnings history and earnings-related data on Viropharma, Inc. (VPHM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BayCom Corp (BCML) Misses Q1 EPS by 4c
• United Bancshares, Inc. (UBOH) Reports Q1 EPS of $0.61
• United Security Bancshares (UBFO) Reports Q1 EPS of $0.24